171 related articles for article (PubMed ID: 37316931)
1. Indole-carbohydrazide linked phenoxy-1,2,3-triazole-N-phenylacetamide derivatives as potent α-glucosidase inhibitors: design, synthesis, in vitro α-glucosidase inhibition, and computational studies.
Emadi M; Mosavizadeh-Marvest F; Asadipour A; Pourshojaei Y; Hosseini S; Mojtabavi S; Faramarzi MA; Larijani B; Mohammadi-Khanaposhtani M; Mahdavi M
BMC Chem; 2023 Jun; 17(1):56. PubMed ID: 37316931
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, in vitro, and in silico biological evaluations of coumarin-indole hybrids as new anti-α-glucosidase agents.
Niri DR; Sayahi MH; Behrouz S; Moazzam A; Mojtabavi S; Faramarzi MA; Larijani B; Rastegar H; Mohammadi-Khanaposhtani M; Mahdavi M
BMC Chem; 2022 Nov; 16(1):84. PubMed ID: 36329490
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, α-glucosidase inhibition, pharmacokinetic, and cytotoxic studies of new indole-carbohydrazide-phenoxy-N-phenylacetamide derivatives.
Hamedifar H; Mohammadi-Khanaposhtani M; Sherafati M; Noori M; Moazam A; Hosseini S; Larijani B; Hajimiri MH; Mahdavi M; Erdogan MK; Gundogdu R; Kirici M; Taslimi P; Gülçin İ
Arch Pharm (Weinheim); 2023 Jun; 356(6):e2200571. PubMed ID: 37017555
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and α-glucosidase-inhibitory activity of phenoxy-biscoumarin-N-phenylacetamide hybrids.
Ansari S; Azizian H; Pedrood K; Yavari A; Mojtabavi S; Faramarzi MA; Golshani S; Hosseini S; Biglar M; Larijani B; Rastegar H; Hamedifar H; Mohammadi-Khanaposhtani M; Mahdavi M
Arch Pharm (Weinheim); 2021 Dec; 354(12):e2100179. PubMed ID: 34467580
[TBL] [Abstract][Full Text] [Related]
5. New phenylthiosemicarbazide-phenoxy-1,2,3-triazole-N-phenylacetamides as dual inhibitors against α-glucosidase and PTP-1B for the treatment of type 2 diabetes.
Ansariashlaghi S; Fakhrioliaei A; Mohammadi-Khanaposhtani M; Noori M; Asadi M; Mojtabavi S; Faramarzi MA; Esfahani EN; Rastegar H; Larijani B; Azizian H; Mahdavi M
Arch Pharm (Weinheim); 2024 Apr; ():e2300517. PubMed ID: 38593290
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and molecular docking studies of diphenylquinoxaline-6-carbohydrazide hybrids as potent α-glucosidase inhibitors.
Pedrood K; Rezaei Z; Khavaninzadeh K; Larijani B; Iraji A; Hosseini S; Mojtabavi S; Dianatpour M; Rastegar H; Faramarzi MA; Hamedifar H; Hajimiri MH; Mahdavi M
BMC Chem; 2022 Jul; 16(1):57. PubMed ID: 35909126
[TBL] [Abstract][Full Text] [Related]
7. New 4-phenylpiperazine-carbodithioate-N-phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α-glucosidase enzymes.
Mohammadi-Khanaposhtani M; Nori M; Valizadeh Y; Javanshir S; Dastyafteh N; Moaazam A; Hosseini S; Larijani B; Adibi H; Biglar M; Hamedifar H; Mahdavi M; Kamci H; Karakus A; Taslimi P
Arch Pharm (Weinheim); 2022 May; 355(5):e2100313. PubMed ID: 35132681
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of α-glucosidase enzyme by 'click'-inspired pharmacophore framework 1,3,4-thiadiazole-1,2,3-triazole hybrids.
Dhameja M; Kumar H; Kurella S; Singh R; Uma A; Gupta P
Future Med Chem; 2023 Feb; 15(4):345-363. PubMed ID: 36942781
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies.
Asgari MS; Mohammadi-Khanaposhtani M; Sharafi Z; Faramarzi MA; Rastegar H; Nasli Esfahani E; Bandarian F; Ranjbar Rashidi P; Rahimi R; Biglar M; Mahdavi M; Larijani B
Mol Divers; 2021 May; 25(2):877-888. PubMed ID: 32189236
[TBL] [Abstract][Full Text] [Related]
10. Quinazolinone-1,2,3-triazole-acetamide conjugates as potent α-glucosidase inhibitors: synthesis, enzyme inhibition, kinetic analysis, and molecular docking study.
Moghadam Farid S; Iraji A; Mojtabavi S; Ghasemi M; Faramarzi MA; Mahdavi M; Barazandeh Tehrani M; Akbarzadeh T; Saeedi M
RSC Med Chem; 2023 Mar; 14(3):520-533. PubMed ID: 36970140
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of a new series of benzofuran-1,3,4-oxadiazole containing 1,2,3-triazole-acetamides as potential α-glucosidase inhibitors.
Abedinifar F; Mohammadi-Khanaposhtani M; Asemanipoor N; Mojtabavi S; Faramarzi MA; Mahdavi M; Biglar M; Larijani B; Hamedifar H; Hajimiri MH
J Biochem Mol Toxicol; 2021 Apr; 35(4):e22688. PubMed ID: 33368871
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and bioactivities evaluation of quinazolin-4(3H)-one derivatives as α-glucosidase inhibitors.
Moheb M; Iraji A; Dastyafteh N; Khalili Ghomi M; Noori M; Mojtabavi S; Faramarzi MA; Rasekh F; Larijani B; Zomorodian K; Sadat-Ebrahimi SE; Mahdavi M
BMC Chem; 2022 Nov; 16(1):97. PubMed ID: 36380337
[TBL] [Abstract][Full Text] [Related]
13. New quinoline-based triazole hybrid analogs as effective inhibitors of α-amylase and α-glucosidase: Preparation,
Khan Y; Iqbal S; Shah M; Maalik A; Hussain R; Khan S; Khan I; Pashameah RA; Alzahrani E; Farouk AE; Alahmdi MI; Abd-Rabboh HSM
Front Chem; 2022; 10():995820. PubMed ID: 36186602
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, α-Glucosidase inhibitory activity and docking studies of Novel Ethyl 1,2,3-triazol-4-ylmethylthio-5,6-diphenylpyridazine-4-carboxylate derivatives.
Firoozpour L; Moghimi S; Salarinejad S; Toolabi M; Rafsanjani M; Pakrad R; Salmani F; Shokrolahi SM; Sadat Ebrahimi SE; Karima S; Foroumadi A
BMC Chem; 2023 Jun; 17(1):66. PubMed ID: 37365646
[TBL] [Abstract][Full Text] [Related]
15. In silico and in vitro studies of thiosemicarbazone-indole hybrid compounds as potent α-glycosidase inhibitors.
Bakherad Z; Bakherad H; Sepehri S; Faramarzi MA; Mahnam K; Mojtabavi S; Mahdavi M
Comput Biol Chem; 2022 Apr; 97():107642. PubMed ID: 35183819
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, in vitro, and in silico enzymatic evaluations of thieno[2,3-b]quinoline-hydrazones as novel inhibitors for α-glucosidase.
Noori M; Rastak M; Halimi M; Ghomi MK; Mollazadeh M; Mohammadi-Khanaposhtani M; Sayahi MH; Rezaei Z; Mojtabavi S; Ali Faramarzi M; Larijani B; Biglar M; Amanlou M; Mahdavi M
Bioorg Chem; 2022 Oct; 127():105996. PubMed ID: 35878449
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Evaluation of 1,3,5-Triaryl-2-Pyrazoline Derivatives as Potent Dual Inhibitors of Urease and α-Glucosidase Together with Their Cytotoxic, Molecular Modeling and Drug-Likeness Studies.
Mehmood R; Sadiq A; Alsantali RI; Mughal EU; Alsharif MA; Naeem N; Javid A; Al-Rooqi MM; Chaudhry GE; Ahmed SA
ACS Omega; 2022 Feb; 7(4):3775-3795. PubMed ID: 35128286
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and in silico studies of quinoline-based-benzo[d]imidazole bearing different acetamide derivatives as potent α-glucosidase inhibitors.
Noori M; Davoodi A; Iraji A; Dastyafteh N; Khalili M; Asadi M; Mohammadi Khanaposhtani M; Mojtabavi S; Dianatpour M; Faramarzi MA; Larijani B; Amanlou M; Mahdavi M
Sci Rep; 2022 Aug; 12(1):14019. PubMed ID: 35982225
[TBL] [Abstract][Full Text] [Related]
20. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
